RT Journal Article
SR Electronic
A1 Kuznar, Wayne
T1 Emerging Therapies for HF Target Different Pathophysiology
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 12
SP 29
OP 30
DO 10.1177/155989771412019
UL http://mdc.sagepub.com/content/14/12/29.abstract
AB Several new agents are being explored for the management of heart failure (HF), which target different pathways involved in this complex disease. This article discusses human stresscopin, as well as a review of neurohumoral modulation, potential advantages of biased ligand at the angiotensin II type 1 receptor, soluble guanylate cyclase (sGC) stimulators, and potassium-binding polymers in HF.